AIT vs CR

The Advanced Deterministic Scorecard reveals a mixed fundamental picture: the Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite strong profitability metrics like ROE of 22.10% and solid earnings growth of 11.4%, the stock trades at a premium valuation (P/E 27.17 vs. sector avg 50.40) with weakening technical momentum (Technical Trend: 10/100). Insider selling worth $11.22M over the last six months raises caution, even as analysts maintain a strong_buy recommendation. The stock is priced above both the Graham defensive value ($107.64) and intrinsic estimate ($248.47), suggesting limited margin of safety.

CR demonstrates stable financial health with a Piotroski F-Score of 6/9 and exceptional liquidity, evidenced by a Current Ratio of 5.53. However, the stock is trading at a severe premium, with the current price of $180.08 vastly exceeding both the Graham Number ($67.44) and the growth-based Intrinsic Value ($41.25). While the company maintains a stellar track record of earnings beats over 25 quarters, the technical trend is currently bearish (0/100) and YoY earnings growth is nearly stagnant at 0.20%. The disconnect between fundamental value and market price suggests a high-quality business that is currently overvalued.